# Fight INflammation to Improve Outcome After Aneurysmal Subarachnoid HEmorRhage

Study · id `cardio:ct-nct05132920` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05132920](<https://clinicaltrials.gov/study/NCT05132920>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05132920

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 334 participants.

## Technical summary

Registry record NCT05132920. Randomized; quadruple masking; primary purpose treatment. Start 2021-12-03 (actual); primary completion 2024-09-09 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 334 participants (enrolled count; ClinicalTrials.gov record NCT05132920, source copy `cardio:ctgov-nct05132920-2026-11-02`, retrieved 2026-11-18)
- Started: 2021-12-03 (actual) (ClinicalTrials.gov record NCT05132920, source copy `cardio:ctgov-nct05132920-2026-11-02`, retrieved 2026-11-18)
- Primary completion: 2024-09-09 (actual) (ClinicalTrials.gov record NCT05132920, source copy `cardio:ctgov-nct05132920-2026-11-02`, retrieved 2026-11-18)
- Completion: 2026-09-09 (actual) (ClinicalTrials.gov record NCT05132920, source copy `cardio:ctgov-nct05132920-2026-11-02`, retrieved 2026-11-18)
- Countries: Germany (ClinicalTrials.gov record NCT05132920, source copy `cardio:ctgov-nct05132920-2026-11-02`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05132920-2026-11-02`, retrieved 2026-11-18)

## The registry's words

- Brief title: Fight INflammation to Improve Outcome After Aneurysmal Subarachnoid HEmorRhage
- Acronym: FINISHER
- Condition: Aneurysmal Subarachnoid Hemorrhage
- Intervention (Drug): Dexamethasone
- Intervention (Drug): Placebo
- Lead sponsor: University Hospital, Bonn
- Lead sponsor class: OTHER
- Collaborator: German Federal Ministry of Education and Research
- Collaborator class: OTHER\_GOV
- Collaborator: Pharmacy of the University Hospital Leipzig- AöR
- Collaborator class: UNKNOWN
- Collaborator: nextevidence GmbH
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Subarachnoid hemorrhage (`cardio:subarachnoid-hemorrhage`)
- Registry lists this organization as a collaborator: German Federal Ministry of Education and Research (`cardio:org-german-federal-ministry-of-education-and-research`)

## Provenance

Content hash: 4a253bf60f34de5f098b5d3558b0593587624bdae2cd26b3e4193231a6923577
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
